Reference
Reference TypeLiterature
TitleThe Peptide Repertoire of HLA-B27 may include Ligands with Lysine at P2 Anchor Position.
AuthorsShira Yair-Sabag; Valentina Tedeschi; Carolina Vitulano; Eilon Barnea; Fabian Glaser; Dganit Melamed Kadosh; Joel D Taurog; Maria Teresa Fiorillo; Rosa Sorrentino; Arie Admon
AffiliationsDepartment of Biology, Technion-Israel Institute of Technology, Haifa, Israel; Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Rome, Italy; Bioinformatics Knowledge Unit, The Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering, Technion-Israel Institute of Technology, Haifa, Israel; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
JournalProteomics
Year2018
AbstractThe HLA-B*27 peptidome has drawn significant attention due to the genetic association between some of the HLA-B*27 alleles and the inflammatory rheumatic disease ankylosing spondylitis (AS), for which a comprehensive biological explanation is still lacking. This study aims to expand the known limits of the HLA-B*27 peptidome to facilitate selection and testing of new peptides, possibly involved in the disease. The HLA peptidomes of HeLa and C1R cell lines stably transfected with the AS-associated HLA-B*27:05 allele, the nonassociated HLA-B*27:09 allele, or their cysteine 67 to serine mutants (C67S), are analyzed on a very large scale. In addition, the peptidomes of HLA-B*27:05 and HLA-B*27:05-C67S are analyzed from the spleens of rats transgenic for these alleles. The results indicate that C67S mutation increases the percentage of peptides with glutamine or lysine at their P2 position (P2-Lys), in both HLA-B*27:05 and HLA-B*27:09. Furthermore, a small fraction of HLA-B*27 peptides contains lysine at their second position (P2), in addition to the more commonly found peptides with arginine (P2-Arg) or the less common glutamine (P2-Gln) located at this anchor position. Overall these data indicate that peptides with P2-Lys should be considered as real ligands of HLA-B*27 molecules and taken into account while looking for putative peptides implicated in the AS.
Curation Last Updated2025-02-27 20:33:26
Epitope
Epitope ID676800
Chemical TypeLinear peptide
Linear SequenceRRNTLIKDTM
Source Molecule Nameexportin, tRNA (nuclear export receptor for tRNAs)
Source OrganismHomo sapiens (human)
Starting Position166
Ending Position175
Epitope Reference Details
Epitope Structure DefinesExact Epitope
Epitope NameRRNTLIKDTM
Location of Data in ReferenceTable S4
In Vivo Processing
Host OrganismRattus norvegicus (brown rat)
In Vivo Process
In Vivo Process TypeNo immunization
MHC Ligand Assay
Qualitative MeasurementPositive
Method/Techniquecellular MHC/mass spectrometry
Measurement ofligand presentation
Antigen Presenting Cells
Cell Tissue TypeBlood
Cell TypeLymphoblast
Cell Culture ConditionsCell Line / Clone
MHC Allele
MHC Allele NameHLA-B*27:05
MHC Evidence CodeElution with MHC specific antibody
MHC Ligand
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceRRNTLIKDTM
Source Molecule Nameexportin, tRNA (nuclear export receptor for tRNAs)
Source OrganismHomo sapiens (human)
Starting Position166
Ending Position175
Assay Reference Details
Assay Comments by IEDB CuratorThe epitope was eluted from C1R or HeLa cells transfected with the HLA, or from spleen cells isolated from HLA transgenic rats.
Location of Assay Data in ReferenceTable S4